Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study.

@article{Gtz2001GeneticVA,
  title={Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study.},
  author={Christopher G{\"o}tz and Paul F. Burke and S E Leurgans and Elizabeth M. Berry-Kravis and Lucia M Blasucci and R. Ramalakshmi Raman and Lili Zhou},
  journal={Archives of neurology},
  year={2001},
  volume={58 2},
  pages={209-13}
}
BACKGROUND Visual hallucinations in Parkinson disease (PD) occur in approximately one third of patients treated long-term with dopaminergic medications. In Alzheimer disease, hallucinations and psychosis have been linked to increased representations of B2/B2 homozyogotes for the dopamine receptor gene DRD1 and 1/1 or 2/2 homozygotes for DRD3. In addition, a previous study of PD patients with and without hallucinations did not show differences in D2 and D3 polymorphisms, although careful case… CONTINUE READING